20
Participants
Start Date
November 30, 2009
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
Patients with a BMI < 30 given Oseltamivir
Patients with a BMI \< 30 given Oseltamivir
Patients with a BMI > 40 given Oseltamivir
Patients with a BMI \> 40 given Oseltamivir
Human Vaccine Challenge Unit, IWK Health Center, Halifax
Lead Sponsor
Canadian Center for Vaccinology
OTHER
Nova Scotia Health Authority
OTHER
Dalhousie University
OTHER
Hoffmann-La Roche
INDUSTRY
IWK Health Centre
OTHER